Literature DB >> 31107443

Determining Bile Duct Density in the Mouse Liver.

Joshua M Adams1, Hamed Jafar-Nejad2.   

Abstract

Mouse is broadly used as a model organism to study biliary diseases. To evaluate the development and function of the biliary system, various techniques are used, including serum chemistry, histological analysis, and immunostaining for specific markers. Although these techniques can provide important information about the biliary system, they often do not present a full picture of bile duct (BD) developmental defects across the whole liver. This is in part due to the robust ability of the mouse liver to drain the bile even in animals with significant impairment in biliary development. Here we present a simple method to calculate the average number of BDs associated with each portal vein (PV) in sections covering all lobes of mutant/transgenic mice. In this method, livers are mounted and sectioned in a stereotypic manner to facilitate comparison among various genotypes and experimental conditions. BDs are identified via light microscopy of cytokeratin-stained cholangiocytes, and then counted and divided by the total number of PVs present in liver section. As an example, we show how this method can clearly distinguish between wild-type mice and a mouse model of Alagille syndrome. The method presented here cannot substitute for techniques that visualize the three-dimensional structure of the biliary tree. However, it offers an easy and direct way to quantitatively assess BD development and the degree of ductular reaction formation in mice.

Entities:  

Year:  2019        PMID: 31107443      PMCID: PMC6555135          DOI: 10.3791/59587

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  28 in total

1.  Development of the intrahepatic biliary tree.

Authors:  James M Crawford
Journal:  Semin Liver Dis       Date:  2002-08       Impact factor: 6.115

2.  Features of Alagille syndrome in 92 patients: frequency and relation to prognosis.

Authors:  K M Emerick; E B Rand; E Goldmuntz; I D Krantz; N B Spinner; D A Piccoli
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

3.  Notch signaling controls liver development by regulating biliary differentiation.

Authors:  Yiwei Zong; Archana Panikkar; Jie Xu; Aline Antoniou; Peggy Raynaud; Frederic Lemaigre; Ben Z Stanger
Journal:  Development       Date:  2009-04-15       Impact factor: 6.868

4.  Transcription factors SOX4 and SOX9 cooperatively control development of bile ducts.

Authors:  Alexis Poncy; Aline Antoniou; Sabine Cordi; Christophe E Pierreux; Patrick Jacquemin; Frédéric P Lemaigre
Journal:  Dev Biol       Date:  2015-05-29       Impact factor: 3.582

5.  Intrahepatic bile ducts are developed through formation of homogeneous continuous luminal network and its dynamic rearrangement in mice.

Authors:  Naoki Tanimizu; Kota Kaneko; Tohru Itoh; Norihisa Ichinohe; Masayuki Ishii; Toru Mizuguchi; Koichi Hirata; Atsushi Miyajima; Toshihiro Mitaka
Journal:  Hepatology       Date:  2016-04-04       Impact factor: 17.425

6.  Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome.

Authors:  Jennifer J Hofmann; Ann C Zovein; Huilin Koh; Freddy Radtke; Gerry Weinmaster; M Luisa Iruela-Arispe
Journal:  Development       Date:  2010-12       Impact factor: 6.868

7.  Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors.

Authors:  Frédéric Clotman; Patrick Jacquemin; Nicolas Plumb-Rudewiez; Christophe E Pierreux; Patrick Van der Smissen; Harry C Dietz; Pierre J Courtoy; Guy G Rousseau; Frédéric P Lemaigre
Journal:  Genes Dev       Date:  2005-08-15       Impact factor: 11.361

8.  Mouse Model of Alagille Syndrome and Mechanisms of Jagged1 Missense Mutations.

Authors:  Emma R Andersson; Indira V Chivukula; Simona Hankeova; Marika Sjöqvist; Yat Long Tsoi; Daniel Ramsköld; Jan Masek; Aiman Elmansuri; Anita Hoogendoorn; Elenae Vazquez; Helena Storvall; Julie Netušilová; Meritxell Huch; Björn Fischler; Ewa Ellis; Adriana Contreras; Antal Nemeth; Kenneth C Chien; Hans Clevers; Rickard Sandberg; Vitezslav Bryja; Urban Lendahl
Journal:  Gastroenterology       Date:  2017-11-21       Impact factor: 22.682

9.  A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.

Authors:  O Skalli; P Ropraz; A Trzeciak; G Benzonana; D Gillessen; G Gabbiani
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

10.  De novo formation of the biliary system by TGFβ-mediated hepatocyte transdifferentiation.

Authors:  Johanna R Schaub; Kari A Huppert; Simone N T Kurial; Bernadette Y Hsu; Ashley E Cast; Bryan Donnelly; Rebekah A Karns; Feng Chen; Milad Rezvani; Hubert Y Luu; Aras N Mattis; Anne-Laure Rougemont; Philip Rosenthal; Stacey S Huppert; Holger Willenbring
Journal:  Nature       Date:  2018-05-02       Impact factor: 49.962

View more
  1 in total

1.  Sox9 Is a Modifier of the Liver Disease Severity in a Mouse Model of Alagille Syndrome.

Authors:  Joshua M Adams; Kari A Huppert; Eumenia C Castro; Mario F Lopez; Nima Niknejad; Sanjay Subramanian; Neda Zarrin-Khameh; Milton J Finegold; Stacey S Huppert; Hamed Jafar-Nejad
Journal:  Hepatology       Date:  2020-01-24       Impact factor: 17.425

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.